Replies to post #23837 on $Bob's and Jbem's Bitchin' Bios

[buckiii2]

ONCS. H.C. Wainwright's Ram Selvaraju anticipates ONCS could apply with Phase IIb data for Breakthrough Therapy designation.

Julie Lamb, Senior Editor-November 10, 2017, 10:24 AM EDT

https://www.smarteranalyst.com/2017/11/10/heres-bull-sees-next-oncosec-medical-inc-oncs-back-phase-ii-combination-trial-success/

[UHD]

VBIV, time is now imo

VBIV, Analyzing VBI Vaccines (VBIV) and Trillium Therapeutics (TRIL)

https://www.google.com/amp/s/stocknewstimes.com/2017/11/15/analyzing-vbi-vaccines-vbiv-and-trillium-therapeutics-tril.html/amp